Clinical Trial Update: Lorcaserin in Obesity: Identification of CNS Targets Using FMRI [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 investigation of lorcaserin for obesity, using fMRI to identify CNS targets involved in weight regulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Belviq (lorcaserin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Obesity, Weight Loss | Phase 4 | Status: ACTIVE_NOT_RECRUITING